A Pill to Prevent COVID-19 Shows Promise
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
UVA Today2d
New Drug Could Block COVID-19 Before It Starts, Study Finds
UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
The Star8d
Merck says research shows its COVID-19 pill works against variants
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant ...
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...
C&EN24d
Long COVID studies stymied by pharma’s lack of cooperation
Nath figured the drug might have a similar effect in people with long COVID, based in part on the PML results. Last June, Nath approached Merck to ask for supplies of Keytruda to test that hypothesis.
Oral antiviral drug proves successful in preventing symptomatic COVID-19 in household members
An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed within households.
Fierce Biotech3d
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
Los Angeles Times26d
Long COVID is solvable, but we need more clinical trials
If public funding supports the development of any new long COVID drug, the data and resulting therapies should be open source and available to manufacturers of generics, which will increase trust ...